Daniel Brennan
Stock Analyst at TD Cowen
(4.92)
# 221
Out of 4,698 analysts
696
Total ratings
58.3%
Success rate
23.7%
Average return
Main Sectors:
Stocks Rated by Daniel Brennan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| A Agilent Technologies | Rated: Buy | $155 → $180 | $149.98 | +20.02% | 41 | Aug 27, 2026 | |
| FRNM Freenome | Initiated Coverage: Buy | $17 | $16.90 | +0.59% | 1 | Aug 18, 2026 | |
| GRAL GRAIL | Reiterated: Buy | $88 | $80.62 | +9.15% | 7 | Aug 14, 2026 | |
| MDXH MDxHealth | Maintained: Buy | $1 | $0.7262 | +37.70% | 13 | Aug 13, 2026 | |
| SERA Sera Prognostics | Maintained: Buy | n/a | $1.98 | - | 16 | Aug 12, 2026 | |
| QTRX Quanterix | Rated: Hold | $4 → $3 | $2.58 | +16.28% | 18 | Aug 11, 2026 | |
| RVTY Revvity | Rated: Buy | $130 | $130.63 | -0.48% | 26 | Aug 7, 2026 | |
| WAT Waters | Upgraded: Buy | $408 → $475 | $413.56 | +14.86% | 29 | Aug 7, 2026 | |
| NTRA Natera | Rated: Buy | $325 → $340 | $327.67 | +3.76% | 27 | Aug 7, 2026 | |
| PACB Pacific Biosciences of California | Maintained: Buy | $3 | $1.30 | +130.77% | 26 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $26.48 | +13.31% | 10 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $10 | $7.54 | +32.63% | 16 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $8.30 | - | 15 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $192 → $210 | $221.66 | -5.26% | 45 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $200 → $210 | $161.04 | +30.40% | 20 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $25 → $28 | $24.57 | +13.96% | 17 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $11 → $15 | $15.19 | -1.25% | 26 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $19 | $17.46 | +8.82% | 23 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $675 | $618.43 | +9.15% | 40 | Jul 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $240 → $236 | $211.03 | +11.83% | 33 | Jul 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $43 → $60 | $59.41 | +0.99% | 26 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $40 → $44 | $43.86 | +0.32% | 26 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $10 → $18 | $16.83 | +6.95% | 16 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $25 → $47 | $63.22 | -25.66% | 33 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $55 → $85 | $87.39 | -2.73% | 20 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $68 → $71 | $64.66 | +9.81% | 20 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $31 → $30 | $25.32 | +18.48% | 9 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 → $34 | $30.57 | +11.22% | 2 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $0.9195 | - | 12 | Apr 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $1.94 | - | 12 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $7 | $3.23 | +116.72% | 21 | Feb 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $183 | $187.62 | n/a | 1 | Jul 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $2.5 | $0.6739 | n/a | 11 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $525 | $121.77 | n/a | 1 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $45 | $50.59 | n/a | 1 | Apr 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $68 → $62 | $7.37 | n/a | 3 | Oct 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $128.71 | n/a | 1 | Oct 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $390 → $465 | $293.35 | n/a | 7 | Aug 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $880 → $1,139 | $1,356.23 | n/a | 12 | May 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $224 → $275 | $271.62 | n/a | 4 | Apr 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $174 → $232 | $163.58 | n/a | 8 | Mar 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $16 | $44.67 | n/a | 1 | Nov 26, 2013 |
Agilent Technologies
Aug 27, 2026
Rated: Buy
Price Target: $155 → $180
Current: $149.98
Upside: +20.02%
Freenome
Aug 18, 2026
Initiated Coverage: Buy
Price Target: $17
Current: $16.90
Upside: +0.59%
GRAIL
Aug 14, 2026
Reiterated: Buy
Price Target: $88
Current: $80.62
Upside: +9.15%
MDxHealth
Aug 13, 2026
Maintained: Buy
Price Target: $1
Current: $0.7262
Upside: +37.70%
Sera Prognostics
Aug 12, 2026
Maintained: Buy
Price Target: n/a
Current: $1.98
Upside: -
Quanterix
Aug 11, 2026
Rated: Hold
Price Target: $4 → $3
Current: $2.58
Upside: +16.28%
Revvity
Aug 7, 2026
Rated: Buy
Price Target: $130
Current: $130.63
Upside: -0.48%
Waters
Aug 7, 2026
Upgraded: Buy
Price Target: $408 → $475
Current: $413.56
Upside: +14.86%
Natera
Aug 7, 2026
Rated: Buy
Price Target: $325 → $340
Current: $327.67
Upside: +3.76%
Pacific Biosciences of California
Aug 6, 2026
Maintained: Buy
Price Target: $3
Current: $1.30
Upside: +130.77%
Aug 6, 2026
Reiterated: Buy
Price Target: $30
Current: $26.48
Upside: +13.31%
Aug 4, 2026
Reiterated: Buy
Price Target: $8 → $10
Current: $7.54
Upside: +32.63%
Aug 4, 2026
Maintained: Buy
Price Target: n/a
Current: $8.30
Upside: -
Jul 31, 2026
Rated: Hold
Price Target: $192 → $210
Current: $221.66
Upside: -5.26%
Jul 31, 2026
Rated: Buy
Price Target: $200 → $210
Current: $161.04
Upside: +30.40%
Jul 30, 2026
Rated: Buy
Price Target: $25 → $28
Current: $24.57
Upside: +13.96%
Jul 29, 2026
Maintained: Hold
Price Target: $11 → $15
Current: $15.19
Upside: -1.25%
Jul 28, 2026
Maintained: Buy
Price Target: $19
Current: $17.46
Upside: +8.82%
Jul 23, 2026
Maintained: Buy
Price Target: $675
Current: $618.43
Upside: +9.15%
Jul 22, 2026
Reiterated: Buy
Price Target: $240 → $236
Current: $211.03
Upside: +11.83%
Jul 15, 2026
Maintained: Hold
Price Target: $43 → $60
Current: $59.41
Upside: +0.99%
Jul 15, 2026
Maintained: Hold
Price Target: $40 → $44
Current: $43.86
Upside: +0.32%
Jul 15, 2026
Rated: Buy
Price Target: $10 → $18
Current: $16.83
Upside: +6.95%
Jul 15, 2026
Maintained: Hold
Price Target: $25 → $47
Current: $63.22
Upside: -25.66%
Jul 15, 2026
Maintained: Buy
Price Target: $55 → $85
Current: $87.39
Upside: -2.73%
Jul 15, 2026
Maintained: Buy
Price Target: $68 → $71
Current: $64.66
Upside: +9.81%
Jul 15, 2026
Rated: Buy
Price Target: $31 → $30
Current: $25.32
Upside: +18.48%
Jul 15, 2026
Maintained: Buy
Price Target: $30 → $34
Current: $30.57
Upside: +11.22%
Apr 28, 2026
Maintained: Buy
Price Target: n/a
Current: $0.9195
Upside: -
Feb 26, 2026
Maintained: Buy
Price Target: n/a
Current: $1.94
Upside: -
Feb 23, 2026
Maintained: Hold
Price Target: $7
Current: $3.23
Upside: +116.72%
Jul 14, 2025
Maintained: Hold
Price Target: $183
Current: $187.62
Upside: n/a
May 6, 2025
Maintained: Buy
Price Target: $2.5
Current: $0.6739
Upside: n/a
Apr 27, 2023
Maintained: Buy
Price Target: $525
Current: $121.77
Upside: n/a
Apr 26, 2023
Maintained: Buy
Price Target: $45
Current: $50.59
Upside: n/a
Oct 15, 2021
Maintained: Buy
Price Target: $68 → $62
Current: $7.37
Upside: n/a
Oct 14, 2021
Initiated Coverage: Buy
Price Target: n/a
Current: $128.71
Upside: n/a
Aug 17, 2021
Maintained: Buy
Price Target: $390 → $465
Current: $293.35
Upside: n/a
May 7, 2021
Maintained: Sell
Price Target: $880 → $1,139
Current: $1,356.23
Upside: n/a
Apr 23, 2021
Maintained: Buy
Price Target: $224 → $275
Current: $271.62
Upside: n/a
Mar 1, 2021
Upgraded: Buy
Price Target: $174 → $232
Current: $163.58
Upside: n/a
Nov 26, 2013
Initiated Coverage: Buy
Price Target: $16
Current: $44.67
Upside: n/a